DE626724C - Process for the production of a preparation by means of which tooth or jaw diseases can be prevented or treated - Google Patents
Process for the production of a preparation by means of which tooth or jaw diseases can be prevented or treatedInfo
- Publication number
- DE626724C DE626724C DER84056D DER0084056D DE626724C DE 626724 C DE626724 C DE 626724C DE R84056 D DER84056 D DE R84056D DE R0084056 D DER0084056 D DE R0084056D DE 626724 C DE626724 C DE 626724C
- Authority
- DE
- Germany
- Prior art keywords
- jaw
- tooth
- preparation
- production
- treated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000002360 preparation method Methods 0.000 title claims description 12
- 238000000034 method Methods 0.000 title claims description 6
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 208000030653 Jaw disease Diseases 0.000 title claims description 4
- 208000010641 Tooth disease Diseases 0.000 title description 2
- 210000001847 jaw Anatomy 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- 230000001174 ascending effect Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 208000014151 Stomatognathic disease Diseases 0.000 claims description 2
- 210000002257 embryonic structure Anatomy 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 210000001909 alveolar process Anatomy 0.000 claims 1
- 210000003456 pulmonary alveoli Anatomy 0.000 claims 1
- 239000008174 sterile solution Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 4
- 244000309466 calf Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 210000003781 tooth socket Anatomy 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000001535 kindling effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cell Biology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Preparation (AREA)
Description
Verfahren zur Herstellung eines Präparates, mittels dessen Zahn- oder Kiefererkrankungen verhütet oder behandelt werden können Die Zahn- und Kiefererkrankungen versuchte man bisher durch verschiedene Arten antiseptischer Behandlungen .einzuschränken bzw. zu behandeln. Nachdem diese Therapie nicht zum Ziele führte, erinnerte man sich der alten Konstitutionstherapie und versuchte durch Zufuhr von Nährstoffen den Gesamtorganismus zu kräftigen mit der Absicht, dabei auch einen therapeutischen Effekt auf die Zahn- und Kiefergewebe ausüben zu können.Process for the production of a preparation, by means of which tooth or Jaw diseases can be prevented or treated The dental and jaw diseases Up to now, attempts have been made to restrict the use of various types of antiseptic treatments or to treat. After this therapy did not work, people remembered adhered to the old constitution therapy and tried by supplying nutrients to strengthen the whole organism with the intention of doing a therapeutic one To be able to exert an effect on the tooth and jaw tissue.
Die vorliegende Erfindung betrifft ein Verfahren zur Gewinnung von Präparaten, die eine spezifische Wirkung gegen die Krankheiten der Zähne und Kieferorgane aufweisen. Bei der Herstellung dieser Präparate wurde von völlig neuartigen Gedanken ausgegangen. Man findet beispielsweise bei kräftigen Menschen, die keinerlei Erkrankungen oder Schwächezustände an irgendwelchen Organen haben, lediglich schlechte Mundverhältnisse. Dieser Umstand weist darauf hin, daß der menschliche Organismus an irgendeiner Stelle seineörtliche Schwäche zeigt, d. h. einen lokalen KonstitutIonsinangel. Im vorliegenden Fall handelt es sich um Konstitutionsfehler oder eine Gewebeschwäche der Kiefergewebe. _ Erfindungsgemäß gelingt es nun, ein Präparat herzustellen, das gerade diejenigen wirksamen Stoffe enthält, die dem eine Gewebsschwäche des Kiefergewebes aufweisenden Organismus fehlen, wenn man als Ausgangsprodukt physiologisch gleichartiges Gewebe embryonaler Natur verwendet. Solches G-ewebe liegt z. B. vor in der embryonalen Zahnsubstanz von Embryonen, jungen Kälbern oder sonstigen jungen, noch im Entwicklungsstadium befindlichen. Schlachttieren (etwa i bis 9o Tage alt), bei denen die das Leben des Zahnes tragende Pulpa noch besonders groß und mit embryonalen Zellen versehen ist; auch das jung angelegte Dentin, ein Teil des Schmelzes, die Zahnfächer (Alveolen), die Zahnfleischp,ar tien und ein größerer Teil des aufsteigenden Astes des Unterkiefers solcher Tiere können verwandt werden.The present invention relates to a method for obtaining Preparations that have a specific effect against diseases of the teeth and jaw organs exhibit. In the process of making these preparations, completely new thoughts were made went out. One finds, for example, strong people who do not have any illnesses or have weakness in any organs, just bad mouth conditions. This fact indicates that the human organism is somewhere shows its local weakness, d. H. a local constitution. In the present In this case, it is a constitutional defect or a tissue weakness of the jaw tissue. _ According to the invention, it is now possible to produce a preparation that just those contains active substances that affect the tissue weakness of the jaw tissue An organism is absent if the starting product is physiologically similar tissue used of an embryonic nature. Such G-ewebe is z. B. before in the embryonic Tooth substance of embryos, young calves or other young ones, still in the development stage located. Animals for slaughter (about 1 to 90 days old), in which the life of the The pulp carrying the tooth is still particularly large and has embryonic cells; also the young dentine, part of the enamel, the tooth sockets (alveoli), the gum pars, ar tia and a larger part of the ascending branch of the lower jaw such animals can be used.
Diese Ausgangsprodukte werden zunächst zerkleinert und zur Herstellung einer Injektionsflüssigkeit extrahiert oder ausgepreßt; die erhaltene Lösung wird enteiweißt, steril filtriert und gegebenenfalls nach Zusatz eines Desinfektionsmittels, wie Thymol, m-Kresiol usw., in Ampullen gefüllt.These starting products are first crushed and used for production extracted or squeezed out of an injection liquid; the solution obtained becomes deproteinized, sterile filtered and, if necessary, after adding a disinfectant, such as thymol, m-cresiol, etc., filled in ampoules.
Ein - p:eroral verabreichbares Trockenpräparat erhält man, wenn man die ebengenannten embryonalen Ausgangsmaterialien. nach Vermahlung bei mäßigen Temperaturen vollkommen von aller Feuchtigkeit befreit und das erhaltene Trockenmehl, gegebenenfalls unter Zusatz anderer Stoffe, zu Tabletten preßt. Auch dem Trockenpräparat kann ein Konservierungsmittel, zweckmäßig vor der Trocknung, zugesetzt wenden.A - p: erorally administrable dry preparation is obtained if one the embryonic starting materials just mentioned. after grinding at moderate temperatures completely freed from all moisture and the dry flour obtained, if necessary with the addition of other substances, presses into tablets. Also the dry preparation can add a preservative, expediently before drying.
'Bei solcher Verarbeitung ist ;eine Zer setzeng des Materials .durch Autolyse zu vermeiden. Die Herstellung von Autolysaten au Zahnsubstanz nichtembryonaler Natur ist an sich beltannt.During such processing, the material will decompose Avoid autolysis. The production of autolysates from nonembryonic tooth substance Nature is in itself bound.
Die Lösung ist zur intravenösen, intramuskulären und subkutanen Darreichung geeignet.The solution is for intravenous, intramuscular and subcutaneous administration suitable.
Die klinische Beobachtung der Wirkungsweise des neuen Präparates vergab, daß dank der Verwendung der ganz neuartig erfaßten Ausgangsprodukte eine Affinität zwischen dem Präparat und den von Karies oder Paradentose befallenen Zahn- und Kieferparti:en besteht, d. h. es werden die aus physiologisch gleichartigem Gewebe erhaltenen Stoffe dort vom geschwächten Kieferorganismus ,aufgenommen, wo Mangel bzw. eingetretene Schäden dies bedingen. Die Wirkung besteht darin, daß durch die Zufuhr des Präparates eine neue Entfachung, Aktivierung oder Stärkung der vitalen Kräfte des Kieferpräparates stattfindet. Dabei werden die transluzenten Zonen, geschwächter Zahnsubstanz gelblichweiß,. kompakt und resistent gegen jedwede Schädigung,exogener oder lendogener Natur. Die Zahn= und Kieferpartien, die durch Paradentose gelitten haben, werden wieder gekräftigt und die lockeren Zähne wieder gefestigt und kautüchtig. Beispiel I -Von dem Ober- und Unterkiefer von zehn Köpfen zwei Monate alter .Kälber werden die Teile, in die die Zähne eingebettet sind, also die Zahnfächer (Alveolen), die Zähne einschließlich des Schmelzes und der Pulpimi, insbesondere auch die noch unentwickelten Zähme, die Zahnfleischpartien und der aufsteigende Ast des Unterkiefers entnommen. Es sind 3ooo bis 35009. Sie werden- gemahlen und bei einer 30° nicht übersteigenden Temperatur zur Trockne gebracht, wobei man .etwa I 5 oo bis 17009 .erhält. Die Masse wird darauf fein gepulvert, in üblicher Weise zu Tabletten gepreßt und ist in dieser Form bereits zu therapeutischer Verwendung geeigüet. Beispiel -- Die nach Beispiel i gewonnenen Teile des Kalbskopfes werden nach dem Mahlen mit io Teilen physiologischer Kochsalzlösung extrahiert. Der wäßrige Extrakt wird mit der zehnfachen Menge Alkohol enteiweißt und die wäßrig-alkoholische Lösung im Vakuum bei 30° von Alkohol befreit. Sie wird hiernach mit oder ohne Zusatz eines I,'-,onservierungsmittels steril auf Ampullen gefüllt. Bei-spie13 Von den in Beispiel i genannten Teilen des ILUbskopfes werden nur die jungen. Zahnpulpen, insbesondere diejenigen der noch unentwickelten Zähne, verarbeitet. Man erhält davon aus zehn Köpfen etwa. 500g, nach dem Trocknen etwa 6o g. Die Pulpa wird nach der in An Beispielen i und 2 geschilderten Weise auf ein Trockenpulver oder auf enteiweißte Injektionsflüssigkeit- weiter verarbeitet.The clinical observation of the mode of action of the new preparation showed that, thanks to the use of the completely newly recorded starting products, there is an affinity between the preparation and the tooth and jaw parts affected by caries or paradentosis, ie the substances obtained from physiologically similar tissue are there by the weakened jaw organism, where deficiency or damage caused it. The effect is that through the supply of the preparation a new kindling, activation or strengthening of the vital forces of the jaw preparation takes place. The translucent zones, weakened tooth substance, turn yellowish white. compact and resistant to any damage, exogenous or lendogenous in nature. The tooth and jaw parts that have suffered from paradentosis are strengthened again and the loose teeth are strengthened again and are able to chew. Example I - From the upper and lower jaw of ten heads two months old. Calves are the parts in which the teeth are embedded, i.e. the tooth sockets (alveoli), the teeth including the enamel and the pulpimi, especially the as yet undeveloped tame , the gums and the ascending branch of the lower jaw removed. There are 3,000 to 35,009. They are ground and brought to dryness at a temperature not exceeding 30 °, whereby about 15,000 to 17009 are obtained. The mass is then finely powdered, pressed into tablets in the usual way and in this form is already suitable for therapeutic use. Example - The parts of the calf's head obtained according to Example i are extracted after grinding with 10 parts of physiological saline solution. The aqueous extract is deproteinized with ten times the amount of alcohol and the aqueous-alcoholic solution is freed from alcohol in vacuo at 30 °. It is then filled in a sterile manner on ampoules with or without the addition of an I, 'preservative. Bei-spie13 Of the parts of the ILUbskopf mentioned in example i, only the young. Tooth pulps, especially those of the still undeveloped teeth, processed. From ten heads you get about. 500g, after drying about 6o g. The pulp is processed further in the manner described in Examples i and 2 on a dry powder or on a deproteinized injection liquid.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DER84056D DE626724C (en) | 1932-02-09 | 1932-02-09 | Process for the production of a preparation by means of which tooth or jaw diseases can be prevented or treated |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DER84056D DE626724C (en) | 1932-02-09 | 1932-02-09 | Process for the production of a preparation by means of which tooth or jaw diseases can be prevented or treated |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE626724C true DE626724C (en) | 1936-03-03 |
Family
ID=7417060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DER84056D Expired DE626724C (en) | 1932-02-09 | 1932-02-09 | Process for the production of a preparation by means of which tooth or jaw diseases can be prevented or treated |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE626724C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE940133C (en) * | 1949-10-18 | 1956-03-08 | Heinrich Schmidt | Process for obtaining highly effective organ extracts |
-
1932
- 1932-02-09 DE DER84056D patent/DE626724C/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE940133C (en) * | 1949-10-18 | 1956-03-08 | Heinrich Schmidt | Process for obtaining highly effective organ extracts |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3705151C2 (en) | ||
| DE3603601C2 (en) | Use of a fenugreek seed extract | |
| DE626724C (en) | Process for the production of a preparation by means of which tooth or jaw diseases can be prevented or treated | |
| CN106729649B (en) | Oral care composition for treating xerostomia and application thereof | |
| DE60311595T2 (en) | COMPOSITION FOR THE TREATMENT OF GASTROINTESTINAL COMPLAINTS | |
| DE3225056C2 (en) | Use of the crushed fenugreek seeds (Trigonella foenum-graecum) as an active ingredient to combat toxic liver damage and / or to improve liver function | |
| MAKANJUOL A et al. | Yoruba traditional healers in psychiatry. II. Management of psychiatric disorders | |
| DE2349186C2 (en) | Medicines to improve cell respiration, heart muscle performance and brain function | |
| DE602004009199T2 (en) | EFFECTS OF SPORODERM-BROKEN GERMINATION-ACTIVATED GANODERMA SPORTS ON THE TREATMENT OF BACKBONE INJURIES AND THE PROLIFERATION AND / OR DIFFERENTIATION OF NEURAL STEM CELLS IN INFRINGED BACKMARK | |
| KR102141623B1 (en) | Composition for prevention or treatment of dental disease comprising an extract of cinnamon | |
| DE2615654C3 (en) | Ointment preparation for intensifying wool and hair growth | |
| CH171175A (en) | Process for the production of a preparation by means of which dental and jaw diseases can be prevented or treated. | |
| LU505164B1 (en) | A medicinal liquid for the treatment of detoxification and healing and its manufacturing process | |
| DE102020104279A1 (en) | Collagen hydrolyzate as an active ingredient against periodontitis or gingivitis | |
| DE894895C (en) | Process for producing a preparation for stimulating tooth preservation | |
| DE2659462A1 (en) | Moist silica hydrogel prodn. for pharmaceutical use - esp. in dental gels for treating parodontal disease | |
| DE2328579A1 (en) | VARICELLA-VACCINE | |
| AT140479B (en) | Process for the production of a preparation by means of which dental and jaw diseases can be prevented or treated. | |
| EP1455806B1 (en) | Active agent mixture containing a plant extract of convolvulaceae for treating hair problems, skin disorders and skin diseases | |
| DE238995C (en) | ||
| METO¹ et al. | Pastes based on royal jelly, an alternative for the minimally invasive treatment of pulpitis (histopathological experimental data) | |
| RU2574362C2 (en) | Method of treating acute pulpitis herbal medicinal product | |
| DE899101C (en) | Wound care products | |
| DE69723417T2 (en) | Propolis extract with improved water solubility | |
| DE391629C (en) | Process for the preparation of a specific remedy for syphilis for internal use |